Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Squamous Cell Lung Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 490 Neoplasms 252 Prostatic Neoplasms 225 Carcinoma, Non-Small-Cell Lung 223 Colorectal Neoplasms 174 Multiple Myeloma 155 Neoplasm Metastasis 124 Lung Neoplasms 118 Leukemia, Myeloid, Acute 104 Leukemia 97 Lymphoma 96 Lymphoma, Follicular 94 Stomach Neoplasms 87 Lymphoma, Non-Hodgkin 87 Precursor Cell Lymphoblastic Leukemia-Lymphoma 82 Ovarian Neoplasms 79 Rectal Neoplasms 77 Head and Neck Neoplasms 77 Colonic Neoplasms 76 Uterine Cervical Neoplasms 74 Pancreatic Neoplasms 73 Carcinoma, Hepatocellular 73 Pain 72 Leukemia, Lymphocytic, Chronic, B-Cell 72 Melanoma 68 Papillomavirus Infections 58 Lymphoma, Large B-Cell, Diffuse 56 Brain Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 54 Recurrence 54

Interventions

iniparib 1 Gemcitabine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01082549 2016-03-17

ECLIPSE

Sanofi

Phase 3 Completed

Squamous Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡